Status:
COMPLETED
Cardiac Rehabilitation for the Treatment of Refractory Angina
Lead Sponsor:
National Heart and Lung Institute
Collaborating Sponsors:
British Heart Foundation
Royal Brompton & Harefield NHS Foundation Trust
Conditions:
Angina Pectoris
Coronary Disease
Eligibility:
All Genders
30-80 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine whether cardiac rehabilitation is a successful treatment for refractory angina, in relation to improvements in cardiovascular risk factors, physical ability, ...
Detailed Description
The majority of patients presenting with angina pectoris resulting from coronary artery disease (CHD) are successfully treated with interventions including coronary artery bypass grafting (CABG) and p...
Eligibility Criteria
Inclusion
- Clinically diagnosed with refractory angina \> 6 months
- Two or more episodes of angina per week
- Males and females aged 30 - 80
- Previous history of single or multiple myocardial infarction (MI), coronary artery bypass graft (CABG), percutaneous transluminal coronary angioplasty (PTCA) or any combination of the above
- Prescribed optimal medical therapy
- AHA exercise and training guidelines classification B and C
- Willing to give written informed consent
Exclusion
- History of any other chronic illness
- AHA exercise and training guidelines classification class D
- Suffer any physical condition for which exercise is a contra-indication
- Participation in two or more periods of planned moderate intensity exercise per week during the past 6 months
- Participation in another research study within the previous 60 days
- History of psychiatric illness
- Unwilling to give written informed consent
Key Trial Info
Start Date :
December 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2010
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT00411359
Start Date
December 1 2006
End Date
April 1 2010
Last Update
April 22 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Heart and Lung Institute, Imperial College London
London, United Kingdom, SW3 6LY